Tokyo Tape
Sign in
← Sundrug

Quarterly report · Q1

9989.TEDINET S100P0LM
Period2022-04-01 → 2022-06-30
Filed2022-08-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥166.5bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥648.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥164.2bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥9.1bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥9.6bn2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥9.2bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥34.7bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.8bn2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥9.2bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥10.0bn2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥23.9bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.8bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥6.8bn2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥326.3bnat 2022-06-30Cons.Assets
Total assets¥325.8bnat 2022-03-31Cons.Assets
Total assets¥308.4bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥103.6bnat 2022-06-30Cons.Liabilities
Total liabilities¥105.2bnat 2022-03-31Cons.Liabilities
Net assets / equity¥222.7bnat 2022-06-30Cons.Net assets
Net assets / equity¥220.6bnat 2022-03-31Cons.Net assets
Net assets / equity¥207.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥88.7bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥89.3bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥53.872022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥204.022021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.182021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥53.862022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥204.012021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥58.182021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio68.2%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio67.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio67.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥12.4bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥12.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥70.4bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2022-04-01 → 2022-06-30¥108.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2022-04-01 → 2022-06-30¥96.1bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2022-04-01 → 2022-06-30¥5.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥178.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥166.5bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥12.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥9.1bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥11.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥11.5bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue2021-04-01 → 2021-06-30¥66.7bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue external2021-04-01 → 2021-06-30¥66.7bn
jpcrp040300-q1r_E03226-000Discount Storereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥3m
jpcrp040300-q1r_E03226-000Discount Storereportable segmentsegment profit2021-04-01 → 2021-06-30¥3.4bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue2021-04-01 → 2021-06-30¥109.0bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue external2021-04-01 → 2021-06-30¥97.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥11.5bn
jpcrp040300-q1r_E03226-000Drug Storereportable segmentsegment profit2021-04-01 → 2021-06-30¥6.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥175.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥164.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥11.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥9.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 329
ItemContextValueUnit
Current liabilitiesPrior1YearInstant96045000000JPY
Current liabilitiesCurrentQuarterInstant94319000000JPY
Net defined benefit liabilityPrior1YearInstant1696000000JPY
Net defined benefit liabilityCurrentQuarterInstant1747000000JPY
Asset retirement obligations nclPrior1YearInstant5300000000JPY
Asset retirement obligations nclCurrentQuarterInstant5347000000JPY
Other nclPrior1YearInstant2133000000JPY
Other nclCurrentQuarterInstant2145000000JPY
Noncurrent liabilitiesPrior1YearInstant9130000000JPY
Noncurrent liabilitiesCurrentQuarterInstant9240000000JPY
LiabilitiesPrior1YearInstant105175000000JPY
LiabilitiesCurrentQuarterInstant103559000000JPY
Capital stockPrior1YearInstant3931000000JPY
Capital stockCurrentQuarterInstant3931000000JPY
Capital surplusPrior1YearInstant7430000000JPY
Capital surplusCurrentQuarterInstant7430000000JPY
Retained earningsPrior1YearInstant215145000000JPY
Retained earningsCurrentQuarterInstant217234000000JPY
Treasury stockPrior1YearInstant-3939000000JPY
Treasury stockCurrentQuarterInstant-3939000000JPY
Shareholders equityPrior1YearInstant222567000000JPY
Shareholders equityCurrentQuarterInstant224656000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant56000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant62000000JPY
Revaluation reserve for landPrior1YearInstant-1940000000JPY
Revaluation reserve for landCurrentQuarterInstant-1940000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-120000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-118000000JPY
Valuation and translation adjustmentsPrior1YearInstant-2003000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant-1996000000JPY
Subscription rights to sharesPrior1YearInstant28000000JPY
Subscription rights to sharesCurrentQuarterInstant29000000JPY
Net assetsPrior1YearInstant220592000000JPY
Net assetsCurrentQuarterInstant222690000000JPY
Liabilities and net assetsPrior1YearInstant325768000000JPY
Liabilities and net assetsCurrentQuarterInstant326250000000JPY
Net salesPrior1YTDDuration164197000000JPY
Net salesCurrentYTDDuration166455000000JPY
Cost of salesPrior1YTDDuration124937000000JPY
Cost of salesCurrentYTDDuration126443000000JPY
Gross profitPrior1YTDDuration39259000000JPY
Gross profitCurrentYTDDuration40012000000JPY
Selling general and administrative expensesPrior1YTDDuration29660000000JPY
Selling general and administrative expensesCurrentYTDDuration30954000000JPY
Operating incomePrior1YTDDuration9599000000JPY
Operating incomeCurrentYTDDuration9058000000JPY
Interest income noiPrior1YTDDuration30000000JPY
Interest income noiCurrentYTDDuration24000000JPY
Dividends income noiPrior1YTDDuration2000000JPY
Dividends income noiCurrentYTDDuration3000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass